Dominique Cathelin

CD4⁺CD25⁺ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

François Ghiringhelli, Nicolas Larmonier, E. Schmitt et al. · European Journal of Immunology · 2004 · 862 citations

T-regulatory Cell, Immunology, Immune Regulation +20

Tumor cells can escape DNA‐damaging cisplatin through DNA endoreduplication and reversible polyploidy

Pierre‐Emmanuel Puig, Marie‐Noëlle Guilly, André Bouchot et al. · Cell Biology International · 2008 · 254 citations · Full text

Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes

Sylvain Audia, Alexandra Nicolas, Dominique Cathelin et al. · Clinical & Experimental Immunology · 2007 · 117 citations · Full text

Administration of Recombinant Soluble Urokinase Receptor Per Se Is Not Sufficient to Induce Podocyte Alterations and Proteinuria in Mice

Dominique Cathelin, Sandrine Placier, Michael Ploug et al. · Journal of the American Society of Nephrology · 2014 · 72 citations · Full text

Podocyte Alterations, Renal Pathology, Immunology +17

Peroxynitrite-Dependent Killing of Cancer Cells and Presentation of Released Tumor Antigens by Activated Dendritic Cells

Jennifer Fraszczak, Malika Trad, Nona Janikashvili et al. · The Journal of Immunology · 2010 · 70 citations · Full text